4th Feb 2021 09:27
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
ODDO BHF CUTS GLAXOSMITHKLINE TO 'NEUTRAL' (OUTPERFORM) - PRICE TARGET 1,490 (1,770) PENCE
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE TO 'SELL' (HOLD) - PRICE TARGET 1,150 (1,400) PENCE
----------
ODDO BHF RAISES RELX TO 'OUTPERFORM' (NEUTRAL)
----------
JEFFERIES RAISES PRUDENTIAL TO 'BUY' ('HOLD') - PRICE TARGET 1,450 (1,455) PENCE
----------
CREDIT SUISSE RAISES ADMIRAL GROUP TARGET TO 2,290 (1,870) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES ST JAMES'S PLACE TARGET TO 1,250 (1,160) PENCE - 'HOLD'
----------
CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 4,100 (3,775) PENCE - 'OUTPERFORM'
----------
RBC RAISES GLENCORE PRICE TARGET TO 300 (280) PENCE - 'OUTPERFORM'
----------
RBC RAISES GLENCORE PRICE TARGET TO 300 (280) PENCE - 'OUTPERFORM'
----------
BARCLAYS RAISES VODAFONE PRICE TARGET TO 175 (170) PENCE - 'OVERWEIGHT'
----------
GOLDMAN SACHS CUTS RIGHTMOVE PRICE TARGET TO 712 (754) PENCE - 'BUY'
----------
UBS RAISES RIGHTMOVE PRICE TARGET TO 630 (620) PENCE - 'NEUTRAL'
----------
GOLDMAN SACHS CUTS AUTO TRADER GROUP PRICE TARGET TO 679 (688) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES DCC PRICE TARGET TO 6,450 (6,300) PENCE - 'OUTPERFORM'
----------
FTSE 250
----------
UBS RAISES CLOSE BROTHERS PRICE TARGET TO 1400 (995) PENCE - 'NEUTRAL'
----------
UBS RAISES ROYAL MAIL TO 'BUY' ('NEUTRAL') - TARGET 445 (320) PENCE
----------
CREDIT SUISSE RAISES DIRECT LINE TARGET TO 405 (320.77) PENCE - 'OUTPERFORM'
----------
PEEL HUNT RAISES DOMINO'S PIZZA TO 'BUY' ('ADD') - TARGET 425 PENCE
----------
OTHER MAIN MARKET AND AIM
----------
JEFFERIES RAISES NCC GROUP PRICE TARGET TO 292 (245) PENCE - 'BUY'
----------
GOLDMAN RAISES ASOS PRICE TARGET TO 6,500 (5,800) PENCE - 'BUY'
----------
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
AdmiralDominosPrudentialRightmoveRelxDirect LineClose BrosAuto TraderVodafoneNccGlaxosmithklineSt James's PlaceRMG.LGlencoreASOSAshtead Group